NAUT (Nautilus Biotechnology) Institutional Ownership: 50.50% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NAUT Nautilus Biotechnology Inc NAUT
22 GF Score
Price $1.74
! 2 Warning Signs
View Full Analysis

What is Nautilus Biotechnology Institutional Ownership?

Nautilus Biotechnology NAUT -1.14% 22 Institutional Ownership is 50.50% as of Jul. 15, 2026. GuruFocus rates NAUT with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nautilus Biotechnology's institutional ownership is 50.50%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nautilus Biotechnology's Insider Ownership is 24.85%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nautilus Biotechnology's Float Percentage Of Total Shares Outstanding is 49.14%.

Nautilus Biotechnology Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Nautilus Biotechnology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nautilus Biotechnology Institutional Ownership Chart

Nautilus Biotechnology Historical Data

The historical data trend for Nautilus Biotechnology can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 3.11 3.12 3.01 3.27 3.34 3.48 3.56 3.29 3.38 5.06
NAUT
22GF Score
Nautilus Biotechnology Inc NAUT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nautilus Biotechnology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 50.50% mean?
Nautilus Biotechnology (NAUT) has a Institutional Ownership of 50.50% as of Jul. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nautilus Biotechnology and its competitors.
Is Nautilus Biotechnology's Institutional Ownership too high?
Nautilus Biotechnology's current Institutional Ownership is 50.50%. Overall, Nautilus Biotechnology has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Nautilus Biotechnology's Institutional Ownership compare to IVVD and ACIU?
Nautilus Biotechnology's Institutional Ownership of 50.50% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nautilus Biotechnology and its competitors. Nautilus Biotechnology's current Institutional Ownership is 50.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nautilus Biotechnology stock overvalued right now?
Nautilus Biotechnology (NAUT) has a current Institutional Ownership of 50.50%. The current Institutional Ownership is 50.50%. Nautilus Biotechnology's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Nautilus Biotechnology (NAUT), the current Institutional Ownership is 50.50% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nautilus Biotechnology Business Description

Address 2701 Eastlake Avenue East, Seattle, WA, USA, 98102
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
22GF Score

Get the complete analysis for NAUT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.74
Price